Alexion Pharmaceuticals, Inc.
Compositions comprising an anti-C5 antibody
Last updated:
Abstract:
The present application relates to methods and compositions employing an antibody that inhibits activation of the complement system and can be used to prevent or treat a pulmonary disease or condition.
Status:
Grant
Type:
Utility
Filling date:
9 Oct 2019
Issue date:
23 Feb 2021